What is a positive expiratory pressure (PEP) mask?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What is a Positive Expiratory Pressure (PEP) Mask?

A PEP mask is a face mask device that delivers 5 to 20 cm H₂O of back pressure during exhalation, designed to improve mucus clearance by increasing gas pressure behind secretions through collateral ventilation and preventing airway collapse during expiration 1.

Device Mechanism and Design

The PEP mask works by creating resistance during the expiratory phase of breathing. When you exhale through the mask, the resistance builds up pressure in your airways that:

  • Increases functional residual capacity (the amount of air remaining in lungs after normal exhalation)
  • Mobilizes secretions by building gas pressure behind mucus via collateral airways
  • Prevents premature airway collapse during expiration, particularly in diseased airways 1, 2

The mask design is specifically important—using a mask rather than a mouthpiece is recommended to avoid air leaks through the upper airways and mouth 2. This ensures the pressure is effectively transmitted to the lower airways where it's needed.

How It Differs from Other Devices

The PEP mask creates a distinct physiological pattern compared to other expiratory pressure devices. With a PEP mask, the expiratory phase shows almost no initial zero-flow period (0.04 seconds) and the end-expiratory pressure returns to zero 3. In contrast, devices like the PEP bottle create a longer zero-flow period (0.39 seconds) with sustained end-expiratory pressure of 9.5 cm H₂O 3. These differences in pressure-flow relationships affect patient tolerance and adherence.

Clinical Application and Technique

The technique involves breathing through the mask at the prescribed pressure (typically 10-15 cm H₂O) for approximately 1 minute, followed by forced expirations (huffs) and coughing, repeated 10 times per session 4. The breathing pattern during PEP use is critical—different patterns can increase or decrease expiratory flow, move the equal pressure point centrally or peripherally, and either increase or decrease lung volume 5.

Evidence-Based Recommendations

In patients with cystic fibrosis, PEP mask therapy is recommended over conventional chest physiotherapy because it is approximately as effective, inexpensive, safe, and can be self-administered 1. This is a Grade B recommendation with fair-level evidence and intermediate benefit 1.

The strongest evidence shows that when used with a mask for at least one year, PEP therapy results in fewer respiratory exacerbations compared to other airway clearance techniques, particularly when compared to high-frequency chest wall oscillation 2. This represents moderate- to high-quality evidence from long-term studies involving 232 participants 2.

Patient Preference

A notable finding across multiple studies is that in all studies with intervention periods of at least one month, patients consistently preferred PEP therapy over other airway clearance methods 1, 2. This preference is clinically significant because adherence to airway clearance regimens directly impacts treatment effectiveness.

Important Caveats

  • Instructions must be individualized based on the desired physiological effect—whether the goal is to increase lung volumes, decrease hyperinflation, or improve airway clearance 5
  • The pressure range matters: standard therapeutic pressure is 10-15 cm H₂O, while sham or subtherapeutic pressure is less than 5 cm H₂O 4
  • Short-term effects on lung function may not be immediately measurable, but long-term use (≥1 year) shows clear benefits in reducing exacerbations 2

Related Questions

Is post‑exposure prophylaxis (PEP) the same as positive expiratory pressure?
In a 13‑day‑old infant presenting with fever and poor feeding, what interventions should emergency medical services (EMS) perform?
How should I manage a 10-month-old infant with a rectal temperature of 100.6 °F and two episodes of vomiting?
What are the differential diagnoses for aggressive behavior in a 10-year-old child?
In a 12‑month‑old male with normal growth and exam, which absent developmental milestone (e.g., pointing to a body part, responding to name, stacking two blocks, using a cup, or walking independently) would be most concerning and warrant further investigation?
How is female pattern hair loss (FPHL) classified using the Ludwig system (and the Sinclair scale)?
Which of the following does NOT characterize polyarteritis nodosa: a) formation of multiple microaneurysms, b) association with hepatitis B infection, c) livedo reticularis, d) involvement of the upper respiratory tract, e) presence of arterial microaneurysms?
What is the mechanism of action of spironolactone in female pattern hair loss?
What is the role of oral progesterone in managing subchorionic hematoma during the first trimester?
What medication, if any, should be added for a patient with known type 2 diabetes mellitus and a current blood glucose of 123 mg/dL who is already taking amlodipine 2 mg and metformin sustained‑release 1 g once daily before lunch?
What is the appropriate cefazolin dosing regimen for treating methicillin‑sensitive Staphylococcus aureus (MSSA) infections in adults, including adjustments for severe infections and renal impairment?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.